The Feline Panleukopenia Virus (FPV) is the causative agent of feline panleukopenia, a highly contagious viral disease that affects domestic and wild cats. The disease has high morbidity and mortality rates, especially in unvaccinated kittens, and is considered one of the leading infectious diseases in feline medicine.
FPV belongs to the Parvoviridae family, genus Protoparvovirus; it is a small, single-stranded DNA virus that is extremely resistant in the environment. Transmission occurs primarily via the fecal-oral route, through contact with feces, secretions, contaminated fomites, and environments with a high viral load.
Clinically, feline panleukopenia is characterized by gastrointestinal and systemic signs, including fever, lethargy, anorexia, vomiting, severe diarrhea, and dehydration. The infection causes severe leukopenia, resulting in severe immunosuppression and a predisposition to secondary infections.
In puppies, the infection can rapidly progress to life-threatening conditions. When the infection occurs during pregnancy, it can result in fetal death, embryonic resorption, or neurological abnormalities, such as cerebellar hypoplasia.
The prevention and control of feline panleukopenia rely primarily on effective vaccination programs, combined with strict hygiene measures, environmental disinfection, and control of contact between susceptible animals. Isolating sick animals is essential to reduce the spread of the virus.
Laboratory testing plays an essential role in the diagnosis and epidemiological surveillance of FPV infection. Molecular methods, such as real-time PCR, enable rapid and sensitive detection of the virus in clinical samples, aiding in diagnostic confirmation and the implementation of immediate public health measures.
Thus, the combination of accurate laboratory diagnosis, appropriate vaccination, biosecurity, and continuous surveillance is essential for controlling feline panleukopenia virus, promoting feline health and reducing the clinical and epidemiological impacts of the disease.
In this context, Bioperfectus’ rapid test for Feline Panleukopenia Virus (FPV) serves as a practical screening tool to support diagnosis and public health surveillance in veterinary clinics, cat shelters, and animal rescue centers. The use of the rapid test allows for the quick identification of suspected cases directly at the point of care, enabling the immediate adoption of measures such as isolation, intensified environmental disinfection, and proper animal handling, as well as referral for laboratory confirmation when necessary. Thus, the rapid test complements conventional diagnostic methods, contributing to the early detection of FPV, the reduction of virus spread, and the strengthening of feline panleukopenia control strategies.
